CVR: 37104469
DKK 2,803,867
Gross profit
Net result: DKK -27,225
No owners listed
CVR · view ownership and management
Director role ended: Sandipkumar Shantilal Kapadia
CVR · 02/09/2020
View the full event history
Intercept Pharma Danmark ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2015 and dissolved in 2020. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 1 employee (2018). In 2019, the company reported a gross profit of DKK 2,803,867 and a net result of DKK -27,225 compared with DKK -7,148,070 the year before. Equity in the 2019 report amounted to DKK -38,893,973.
Source: annual reports filed with the Danish Business Authority.
Compared to 407 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. Intercept Pharma Danmark ApS is registered in the Danish CVR register with the status Dissolved and ceased on 2 September 2020.
Intercept Pharma Danmark ApS was founded on 23 September 2015.
Intercept Pharma Danmark ApS was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler (industry code 464610).
Intercept Pharma Danmark ApS had 1 employee in 2018 according to the Danish CVR register.
In 2019, Intercept Pharma Danmark ApS reported a gross profit of DKK 2,803,867.
Intercept Pharma Danmark ApS was located at c/o Harbour House, Sundkrogsgade 21, 2100 København Ø.
As of September 2, 2020, Sandipkumar Shantilal Kapadia has stepped down as director of Intercept Pharma Danmark ApS.
Intercept Pharma Danmark ApS was dissolved on September 2, 2020.
As of July 3, 2020, Daniel Hood has stepped down as director of Intercept Pharma Danmark ApS.
Intercept Pharma Danmark ApS has published its annual report for 2019. Gross profit came to DKK 2,803,867, and the net result was DKK -27,225.
Intercept Pharma Danmark ApS has published its annual report for 2018. Gross profit came to DKK 1,052,615, and the net result was DKK -7,148,070.
Intercept Pharma Danmark ApS has published its annual report for 2017. Gross profit came to DKK -9,176,767, and the net result was DKK -25,789,009.
As of January 11, 2018, Daniel Hood is registered as director of Intercept Pharma Danmark ApS.
As of December 31, 2017, Seokho Bryan Yoon has stepped down as director of Intercept Pharma Danmark ApS.
As of December 31, 2017, Gülizar Aybasti Skjoldager has stepped down as director of Intercept Pharma Danmark ApS.
Intercept Pharma Danmark ApS has published its interim report for the period September 23, 2015 – December 31, 2016.
As of May 30, 2017, Sandipkumar Shantilal Kapadia is registered as director of Intercept Pharma Danmark ApS.
As of May 30, 2017, Barbara Duncan has stepped down as director of Intercept Pharma Danmark ApS.
As of September 23, 2015, Seokho Bryan Yoon is registered as director of Intercept Pharma Danmark ApS.
As of September 23, 2015, Barbara Duncan is registered as director of Intercept Pharma Danmark ApS.
As of September 23, 2015, Gülizar Aybasti Skjoldager is registered as director of Intercept Pharma Danmark ApS.
Intercept Pharma Danmark ApS was founded on September 23, 2015.
Companies in the same industry and area
CVR 45346951
CVR 45929698
CVR 46098765
CVR 19064301
CVR 37726508
